MammaTyper in vitro diagnostic test for determining breast cancer subtypes

  • Medtech innovation briefing
  • MIB135
  • Published: 
Download (PDF)

Regulatory information

MammaTyper was CE marked as an in vitro diagnostic medical device in 2014.